by TractManager | Apr 25, 2019 | Emerging Technology Report
The TransPyloric Shuttle Device is an endoscopically placed gastric-occupying device for weight reduction in adult patients with a BMI of 35.0 kg/m2 to 40.0 kg/m2 or a BMI of 30.0 kg/m2 to 34.9 kg/m2 with at least 1 obesity-related comorbidity. The device is comprised...
by TractManager | Apr 25, 2019 | Health Technology Assessment
Health Problem: Psoriasis is an immune-mediated disease of the skin that affects 7.5 million people in the United States and is characterized by the appearance of red, thickened, scaly patches on the skin. Technology Description: Laser therapy typically involves...
by TractManager | Apr 25, 2019 | Health Technology Assessment
Health Problem: Approximately 3.2 million people in the United States have a chronic hepatitis C virus (HCV) infection, which puts them at risk for developing hepatic fibrosis or cirrhosis, a need for liver transplantation, and possible death due to liver failure or...
by TractManager | Apr 25, 2019 | Emerging Technology Report
The TransPyloric Shuttle Device is an endoscopically placed gastric-occupying device for weight reduction in adult patients with a BMI of 35.0 kg/m2 to 40.0 kg/m2 or a BMI of 30.0 kg/m2 to 34.9 kg/m2 with at least 1 obesity-related comorbidity. The device is comprised...
by TractManager | Apr 19, 2019 | Emerging Technology Report
Plenity (formerly Gelesis100 and GSP3) is an oral, non-systemic, superabsorbent hydrogel intended as an aid in weight management in overweight and obese adults with a body mass index (BMI) of 25-40 kg/m2, when used in conjunction with diet and exercise.If you have a...
Recent Comments